ES2150848A1 - Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseases - Google Patents

Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseases

Info

Publication number
ES2150848A1
ES2150848A1 ES009800791A ES9800791A ES2150848A1 ES 2150848 A1 ES2150848 A1 ES 2150848A1 ES 009800791 A ES009800791 A ES 009800791A ES 9800791 A ES9800791 A ES 9800791A ES 2150848 A1 ES2150848 A1 ES 2150848A1
Authority
ES
Spain
Prior art keywords
methyloxy
countering
inflammation
naphthyl substituted
vascular diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800791A
Other languages
Spanish (es)
Other versions
ES2150848B1 (en
Inventor
Calahorra Francisco Lopez
Castrillo Dolores Velasco
Via Josep Marti
Carbo Berta Ballart
Avellana Jaime Pascual
Perez M Luisa Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to ES9800791A priority Critical patent/ES2150848B1/en
Publication of ES2150848A1 publication Critical patent/ES2150848A1/en
Application granted granted Critical
Publication of ES2150848B1 publication Critical patent/ES2150848B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The set of methyloxy naphthyl substituted heterocyclics comprises therapeutic products countering leucotriene attack. Each product contains a sulphur and a nitrogen atom with methyloxy naphthyl substitution, and pharmaceutically acceptable salts and solvates. The products are effective against inflammation, allergies and cardio vascular illnesses.
ES9800791A 1998-04-15 1998-04-15 HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS. Expired - Fee Related ES2150848B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9800791A ES2150848B1 (en) 1998-04-15 1998-04-15 HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9800791A ES2150848B1 (en) 1998-04-15 1998-04-15 HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS.

Publications (2)

Publication Number Publication Date
ES2150848A1 true ES2150848A1 (en) 2000-12-01
ES2150848B1 ES2150848B1 (en) 2001-07-01

Family

ID=8303461

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800791A Expired - Fee Related ES2150848B1 (en) 1998-04-15 1998-04-15 HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS.

Country Status (1)

Country Link
ES (1) ES2150848B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104178A1 (en) * 2002-06-07 2003-12-18 Cortical Pty Ltd Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032018T3 (en) * 1987-07-31 1993-01-01 American Home Products Corporation PROCEDURE FOR THE PREPARATION OF NAFTILPROPIONIC ACID DERIVATIVES.
ES2103181A1 (en) * 1994-08-01 1997-08-16 Menarini Lab Naphthalene amides having leukotriene-antagonistic action

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2032018T3 (en) * 1987-07-31 1993-01-01 American Home Products Corporation PROCEDURE FOR THE PREPARATION OF NAFTILPROPIONIC ACID DERIVATIVES.
ES2103181A1 (en) * 1994-08-01 1997-08-16 Menarini Lab Naphthalene amides having leukotriene-antagonistic action

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003104178A1 (en) * 2002-06-07 2003-12-18 Cortical Pty Ltd Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
GB2405146A (en) * 2002-06-07 2005-02-23 Cortical Pty Ltd Napthalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)

Also Published As

Publication number Publication date
ES2150848B1 (en) 2001-07-01

Similar Documents

Publication Publication Date Title
IT8422397A0 (en) AROMATIC ESTERS AND AMIDES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.
BR9306421A (en) New n-aryl and n-heteroarylurea derivatives as acylcoenzyme a inhibitors: cholesterol acyltransferase (acat)
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
RS50485B (en) Therapeutic combinations comprising amlodipin and atorvastatin
WO1998016507A3 (en) New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
DE69117868T2 (en) SPRAYING TARGET AND THEIR PRODUCTION
ITRM920412A1 (en) HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE.
IS1812B (en) Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use
EP0888776A4 (en) A product of heat treatment of uronic acid, food, drink or drug including the product
ITMI920256A0 (en) DIETARY AND/OR PHARMACEUTICAL COMPOSITIONS BASED ON FREEZE-DRIED LACTIC BACTERIA, THEIR PREPARATION AND USE
NO934282D0 (en) Calcium, trace metal, vitamin D and drug therapy combinations
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
EP0719791A3 (en) Medicaments for the treatment of restenosis and arterial sclerosis
HU913137D0 (en) 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use
EE03663B1 (en) Method of preventing breast cancer, pharmaceutical preparation and product, and use of the active ingredient
HK1018211A1 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/dydrogen exchanger and a medicament for the treatment of cardiovascular diseases.
AU3366899A (en) Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
NO962752D0 (en) Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis
NO305286B1 (en) Quinoxaline compounds, pharmaceutical preparations comprising them, and their use in the manufacture of medicaments
NO990335D0 (en) Arylic cycloalkanecarboxyl esters, their use, pharmaceutical compositions and preparation
HUP9901376A3 (en) 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same
ES2150848A1 (en) Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseases
ZA977606B (en) Antimicrobial medical devices and methods of production and use.
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20001201

Kind code of ref document: A1

Effective date: 20001201

FD1A Patent lapsed

Effective date: 20060417